找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: HMG-CoA Reductase Inhibitors; Gerd Schmitz,Michael Torzewski Book 2002 Springer Basel AG 2002 atherosclerosis.cardiovascular.coronary arte

[復(fù)制鏈接]
樓主: 指責
21#
發(fā)表于 2025-3-25 05:03:52 | 只看該作者
22#
發(fā)表于 2025-3-25 08:41:54 | 只看該作者
23#
發(fā)表于 2025-3-25 11:44:58 | 只看該作者
Michael D. Robinson,Michael Eid hypercholesterolemia [.]. Clinical trials have demonstrated that they can induce regression of vascular atherosclerosis, as well as reduction of cardiovascular-related morbidity and mortality, in patients with and without coronary artery disease CAD [.–.]. These trials provide a powerful endorsemen
24#
發(fā)表于 2025-3-25 17:22:12 | 只看該作者
Swarup Bhunia,Mark M.‘Tehranipoortible to rupture or fissuring, thereby being a focus of high risk for thrombus formation. Rupture with consecutive thrombus formation can cause an acute coronary syndrome, such as unstable angina or myocardial infarction. So far reduction of plasma cholesterol by lipid-lowering therapy has been show
25#
發(fā)表于 2025-3-25 22:26:03 | 只看該作者
26#
發(fā)表于 2025-3-26 00:57:08 | 只看該作者
27#
發(fā)表于 2025-3-26 04:37:57 | 只看該作者
28#
發(fā)表于 2025-3-26 08:42:03 | 只看該作者
Sterol-regulatory element binding proteins (SREBPs): gene-regulatory target of statin action,tible to rupture or fissuring, thereby being a focus of high risk for thrombus formation. Rupture with consecutive thrombus formation can cause an acute coronary syndrome, such as unstable angina or myocardial infarction. So far reduction of plasma cholesterol by lipid-lowering therapy has been show
29#
發(fā)表于 2025-3-26 13:37:23 | 只看該作者
30#
發(fā)表于 2025-3-26 18:28:43 | 只看該作者
Cost-effectiveness of statins in primary and secondary prevention of coronary heart disease,as the elderly, will also be considered. In addition, we will also consider the relative cost-effectiveness of different statin therapies. Finally, we will consider the cost-effectiveness of statin therapy and resource utilisation in relation to healthcare provision.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 03:04
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
陕西省| 临泽县| 礼泉县| 富裕县| 治县。| 崇文区| 迁安市| 安陆市| 金秀| 英吉沙县| 江陵县| 抚顺市| 洛南县| 二连浩特市| 渭南市| 祥云县| 洞头县| 澳门| 抚宁县| 肃宁县| 乐山市| 青田县| 民勤县| 云霄县| 哈密市| 龙南县| 区。| 东港市| 马鞍山市| 英吉沙县| 大连市| 曲沃县| 广丰县| 茌平县| 图木舒克市| 苏尼特左旗| 洛扎县| 额敏县| 乌审旗| 新余市| 韶关市|